Print
Email
Print Edition Stories
Tuesday, November 9, 2010
Boston Scientific begins trial of device to treat Parkinson's disease
By Michelle Lang
MHT's Galen Moore: Mass. companies building to be sold
Raytheon unveils updated exoskeleton robotics suit
Natick medical devices giant Boston Scientific Corp. has begun to enroll patients in a clinical trial of the company’s Vercise Deep Brain Stimulation System made to treat Parkinson’s disease.
Called the Vantage clinical trial, it will enroll 40 patients in Europe, Boston Scientific officials reported in a press release. The patients will be implanted with the Vercise system, a neurostimulation device that is designed to send electrical signals to certain parts of the brain.
Read more about the Boston Scientific clinical trial of the Vercise Deep Brain Stimulation System.
Boston Scientific announced in October that it had signed a deal for its Neurovascular business to be acquired by Stryker Corp. for $1.5 billion in cash.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
